Use of Valdoxan (Agomelatin) in the Combined Treatment of Moderate and Severe Nonpsychotic Depression

By Medvedev V.  

Neuroscience and Behavioral Physiology, Vol. 43, Iss. 7, 2013-09 ,pp. : 878-882

Springer Publishing Company

Access to resources Recommend Favorite

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)

By Muller M.J.   Himmerich H.   Kienzle B.   Szegedi A.  

Journal of Affective Disorders, Vol. 77, Iss. 3, 2003-12 ,pp. : 255-260

Elsevier

Access to resources Recommend Favorite

Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK

By Borghi J.   Guest J.F.  

European Psychiatry, Vol. 15, Iss. 6, 2000-09 ,pp. : 378-387

Elsevier

Access to resources Recommend Favorite

Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in Austria

By Brown M.C.J.   Nimmerrichter A.A.   Guest J.F.  

European Psychiatry, Vol. 14, Iss. 4, 1999-07 ,pp. : 230-244

Elsevier

Access to resources Recommend Favorite

Interpersonal psychotherapy for Finnish community patients with moderate to severe major depression and comorbidities: A pilot feasibility study

By Karlsson Hasse   Säteri Ulla   Markowitz John C.  

Nordic Journal of Psychiatry, Vol. 65, Iss. 6, 2011-12 ,pp. : 427-432

Informa Healthcare

Access to resources Recommend Favorite